CuResponse
Dr. Salpeter has deep experience in developing and bringing new biotechnologies to market. He previously served as Chief Scientist and VP Business Development at Sight Diagnostics and worked in pharmaceuticals as a Pharmaceutical Analyst at Biotechnology General (Ferring). Dr. Salpeter holds a Ph.D in Biochemistry from the Hebrew University and performed post-doctoral studies at the Institute for Drug Research, the Hebrew University School of Pharmacy.
This person is not in any offices
CuResponse
Curesponse is a medical company developing a three-dimensional tissue culture system for modeling cancer growth and drug response.